Actavis Acquiring Warner Chilcott For $8.5 Billion – ValueWalk Premium

Actavis Acquiring Warner Chilcott For $8.5 Billion

Actavis Inc (NYSE:ACT) today announced its definitive agreement to acquire Warner Chilcott plc (NASDAQ:WCRX) in an all stock transaction valued at approximately $8.5 billion.

Actavis, Warner Chilcott Deal:

The generic drug maker Actavis Inc (NYSE:ACT) is to acquire the specialty pharmaceutical company Warner Chilcott.

The deal  means that Warner Chilcott shareholders to receive 0.16  shares of Actavis for each Warner Chilcott . . .


This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.

Saved Articles